Reason for request
Extension of indication
Clinical Benefit
| Substantial |
The actual benefit of BERINERT is substantial in th is extension of the indication to the short-term pre-procedure prevention of acute HAE episodes. |
Clinical Added Value
| no clinical added value |
For the short-term pre-procedure prevention of acute HAE episodes, BERINERT does not provide any improvement in actual benefit (IAB V, non-existent) over other treatments already available. |
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
rB2y0YYexCYNNds2
